Mercado de terapias digitales con receta (PDTx) en Asia-Pacífico: tendencias de la industria y pronóstico hasta 2029

Personalice su informePersonalice su informe Compre ahoraCompre ahora Ejemplo de informe gratuitoEjemplo de informe gratuito
Hogar Pharmaceutical Asia Pacific Prescription Digital Therapeutics Dtx Market
Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado de terapias digitales con receta (PDTx) en Asia-Pacífico: tendencias de la industria y pronóstico hasta 2029

  • Pharmaceutical
  • Upcoming Report
  • May 2022
  • Asia-Pacific
  • 350 Páginas
  • Número de tablas: 220
  • Número de figuras: 60
Comprar ahoraComprar ahora

Asia Pacific Prescription Digital Therapeutics Dtx Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) :  % Diagram

Diagram Período de pronóstico
 2022 –2029
Diagram Tamaño del mercado (año base)
 USD 96.38 Billion
Diagram Tamaño del mercado (año de pronóstico)
 USD 545.70 Billion
Diagram Tasa de crecimiento anual compuesta (CAGR)
 %
Diagram Jugadoras de los principales mercados
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Solicitud de desbloqueo

>Mercado de terapias digitales con receta (PDTx) de Asia y el Pacífico , por mecanismo (mecanismos de entrada, mecanismos de salida), categoría ( aumento de la medicación , reemplazo de medicación), tratamiento (tratamiento ambulatorio, monoterapia), software (software para afecciones respiratorias, software para salud mental , software para trastornos por consumo de opioides, software para diabetes, otros), servicios (microservicios conductuales, microservicios médicos), accesibilidad de aplicaciones (Android, iOS, Windows), tipo de aplicación (aplicaciones nativas, aplicaciones web), aplicación (trastorno por consumo de sustancias (SUD), trastorno por consumo de opioides (OUD), trastorno por déficit de atención e hiperactividad (TDAH), enfermedad de Alzheimer, trastorno depresivo mayor (MDD), insomnio, epilepsia, trastorno del movimiento, esclerosis múltiple, migraña, trastorno del espectro autista, oncología, inflamación, respiratorio, cardiovascular, manejo del dolor, afecciones metabólicas, otros), pacientes (niños, Adultos) – Tendencias de la industria y pronóstico hasta 2029

Mercado de terapias digitales con receta (PDTx) en Asia y el Pacífico

Análisis y tamaño del mercado                              

Las terapias digitales de prescripción son una estrategia única que permite que las implementaciones de software traten rápidamente las principales enfermedades. Está diseñada para brindar un tratamiento basado en evidencia en cualquier lugar y en cualquier momento y brindar a los médicos datos en tiempo real sobre el progreso del paciente. Se han desarrollado terapias digitales de prescripción y están en la etapa de desarrollo para una variedad de enfermedades, incluido el trastorno por consumo de sustancias (SUD), el trastorno por consumo de opioides (OUD), el TDAH, el trastorno depresivo mayor (MDD), el insomnio , la esclerosis múltiple, la oncología, la migraña , la epilepsia, el trastorno del espectro autista y la enfermedad cardiovascular. Los pacientes con diversas necesidades no satisfechas pueden encontrar que las terapias digitales de prescripción son el aspecto más crucial de sus vidas.

Data Bridge Market Research analiza que el mercado de terapias digitales con prescripción (PDTx) de Asia-Pacífico se valoró en USD 96,38 millones en 2021 y se espera que alcance los USD 545,70 millones para 2029, registrando una CAGR del 24,2% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Métrica del informe

Detalles

Período de pronóstico

2022 a 2029

Año base

2021

Años históricos

2020 (Personalizable para 2014 - 2019)

Unidades cuantitativas

Ingresos en millones de USD, volúmenes en unidades, precios en USD

Segmentos cubiertos

Mecanismo (mecanismos de entrada, mecanismos de salida), categoría (aumento de la medicación, reemplazo de medicación), tratamiento (tratamiento ambulatorio, monoterapia), software (software para afecciones respiratorias, software para salud mental, software para trastornos por consumo de opioides, software para diabetes, otros), servicios (microservicios conductuales, microservicios médicos), accesibilidad de aplicaciones (Android, iOS, Windows), tipo de aplicación (aplicaciones nativas, aplicaciones web), aplicación (trastorno por consumo de sustancias (SUD), trastorno por consumo de opioides (OUD), trastorno por déficit de atención e hiperactividad (TDAH), enfermedad de Alzheimer, trastorno depresivo mayor (MDD), insomnio, epilepsia, trastorno del movimiento, esclerosis múltiple, migraña, trastorno del espectro autista, oncología , inflamación, respiratorio, cardiovascular, manejo del dolor, afecciones metabólicas, otros), pacientes (niños, adultos),

Países cubiertos

China, Japón, India, Corea del Sur, Singapur, Malasia, Australia, Tailandia, Indonesia, Filipinas, Resto de Asia-Pacífico (APAC) en Asia-Pacífico (APAC)

Actores del mercado cubiertos

ResMed (EE. UU.), SAMSUNGHEALTHCARE (Corea del Sur), Biofourmis (EE. UU.), Novartis AG (Suiza), Medtronic (Irlanda), Pear Therapeutics, Inc. (EE. UU.), Voluntis (Francia)

Oportunidades de mercado
  • Aumento del número de actividades de investigación y desarrollo
  • Fuerte cartera de productos potenciales

Definición de mercado

Las terapias digitales con receta son un tipo de software que se utiliza para tratar una variedad de enfermedades. Los medicamentos digitales con receta se crearon combinando biología y tecnología. La inteligencia artificial, diversos algoritmos y realidad virtual se utilizan para crear estos instrumentos terapéuticos. Los pacientes pueden usar software y servicios de terapias digitales con receta para obtener cualquier tipo de tratamiento cuando y donde lo necesiten. Los tratamientos digitales con receta han ganado mucha popularidad ya que están estrictamente regulados por la FDA y otras autoridades regulatorias y solo se pueden usar con una receta médica adecuada.

Dinámica del mercado de terapias digitales con receta (PDTx) en Asia y el Pacífico

Conductores

  • Aumento de la prevalencia de enfermedades crónicas

La creciente prevalencia de enfermedades crónicas es un factor importante que impulsa la tasa de crecimiento del mercado de terapias digitales con receta (PDTx) durante el período de pronóstico de 2022 a 2029. Según la Organización Mundial de la Salud (OMS), 463 millones de adultos tendrían diabetes en 2020. Según las predicciones, habrá aproximadamente 629 millones de diabéticos en todo el mundo para 2045.

  • Aumentar la inversión en infraestructura sanitaria

Otro factor importante que influye en la tasa de crecimiento del mercado de terapias digitales con receta (PDTx) es el aumento del gasto sanitario, que ayuda a mejorar su infraestructura. Además, varias organizaciones gubernamentales tienen como objetivo mejorar la infraestructura sanitaria aumentando la financiación, lo que influirá aún más en la dinámica del mercado.

Furthermore, rising adoption rate of smartphones and tablets will expand the prescription digital therapeutics (PDTx) market. Additionally, increasing government initiatives for better healthcare services and surging geriatric population will result in the expansion of prescription digital therapeutics (PDTx) market. Along with this, easy accessibility, patient comfort, and the potentiality to influence behavioural change will enhance the market's growth rate.

Opportunities

  • Strong pipeline of potential products

A significant pipeline of potential items projected to be released throughout the forecast period will provide beneficial opportunities for the prescription digital therapeutics (PDTx) market growth. Pear-011 (anxiety GAD), Pear-015 (depression MDD), which are used in the treatment of adults with chronic insomnia and depression, and CT-152 (major depressive disorder), CT-155 (schizophrenia), which are used in the treatment of adults with schizophrenia and depression, are illustrations of potential pear therapeutics clinical therapeutics products in phase III. As a result, various late-stage drugs in the pipeline are anticipated to give attractive prospects for the digital therapeutics market to flourish.

The market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the biologics market growth. Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of prescription digital therapeutics (PDTx) during the forecast period.

Restraints/Challenges

On the other hand, patient data privacy concerns will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the prescription digital therapeutics (PDTx) market. Additionally, strict government regulations and lack of awareness about digital therapeutics in developing countries will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This Asia-Pacific prescription digital therapeutics (PDTx) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific prescription digital therapeutics (PDTx) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Prescription digital therapeutics (PDTx) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Asia-Pacific Prescription Digital Therapeutics (PDTx) Market

COVID-19 has a positive general influence on the prescription digital therapeutics (PDTx) sector. Due to increased global awareness of the relevance of digital health, the prevalence of mental illness, and the rate of drug usage. Furthermore, because individuals were forced to stay at home during the pandemic, less physical exercise, an unhealthy lifestyle, and mental stress increased the prevalence of chronic diseases. As a result, demand for prescription digital therapeutics (PDTx) devices and software is increasing around the world. The industry is expected to increase further since regulatory clearances for prescription digital therapeutics (PDTx)-based treatments have recently been eased.

In the middle of the COVID-19 outbreak, the US FDA issued provisional advice for Pear Therapeutics' mental health medications. It also implies that regulatory agencies recognize the significance of digital therapeutics goods. In addition, digital health businesses in the United States raised USD 5.4 billion in venture capital in the first half of 2020, a record high in the history of digital health funding, indicating that investors believe these solutions are necessary. Hence, the COVID-19 pandemic is predicted to boost the market for prescription digital therapeutics (PDTx).

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Scope

The Asia-Pacific prescription digital therapeutics (PDTx) market is segmented on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Mechanism

  • Input Mechanisms
  • Output Mechanisms

Category

  • Medication Augmentation
  • Medication Replacement

Treatment

  • Outpatient Treatment
  • Monotherapy

Software

  • Software for Respiratory Conditions
  • Software for Mental Health
  • Software for Opioid Use Disorder
  • Software for Diabetes
  • Others

Services

  • Behavioral Microservices
  • Medical Microservices

App Accessibility

  • Android
  • iOS
  • Windows

App Type

  • Native Apps
  • Web Apps

Application

  • Substance Use Disorder (SUD)
  • Opioid Use Disorder (OUD)
  • Attention Deficit/Hyperactivity Disorder (ADHD)
  • Alzheimer’s Disease
  • Major Depressive Disorder (MDD)
  • Insomnia
  • Epilepsy
  • Movement Disorder
  • Multiple Sclerosis
  • Migraña
  • Trastorno del espectro autista
  • Oncología
  • Inflamación
  • Respiratorio
  • Cardiovascular
  • Manejo del dolor
  • Condiciones metabólicas
  • Otros

Pacientes

  • Niños
  • Adultos

Análisis y perspectivas regionales del mercado de terapias digitales con receta (PDTx) en Asia y el Pacífico

Se analiza el mercado de terapias digitales con prescripción (PDTx) de Asia y el Pacífico y se proporcionan información y tendencias del tamaño del mercado por país, mecanismo, categoría, tratamiento, software, servicios, accesibilidad de la aplicación, tipo de aplicación, aplicación y pacientes como se mencionó anteriormente.

Los países cubiertos en el informe del mercado de terapias digitales con prescripción (PDTx) de Asia-Pacífico son China, Japón, India, Corea del Sur, Singapur, Malasia, Australia, Tailandia, Indonesia, Filipinas, Resto de Asia-Pacífico (APAC) en Asia-Pacífico (APAC).

Japón domina el mercado de terapias digitales con receta (PDTx) de Asia-Pacífico en términos de participación de mercado e ingresos de mercado y seguirá fortaleciendo su dominio durante el período de pronóstico. Esto se debe a que el aumento del gasto en atención médica y la creciente prevalencia de enfermedades crónicas impulsarán aún más la tasa de crecimiento del mercado en esta región.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas de Asia-Pacífico y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado de la terapia digital con receta (PDTx) en Asia-Pacífico

El panorama competitivo del mercado de terapias digitales con receta (PDTx) de Asia-Pacífico proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia en Asia-Pacífico, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de terapias digitales con receta (PDTx) de Asia-Pacífico.

Algunos de los principales actores que operan en el mercado de terapias digitales con prescripción (PDTx) de Asia-Pacífico son:

  • ResMed (Estados Unidos)
  • SAMSUNGHEALTHCARE (Corea del Sur)
  • Biofourmis (Estados Unidos)
  • Novartis AG (Suiza)
  • Medtronic (Irlanda)
  • Pear Therapeutics, Inc. (Estados Unidos)
  • Voluntis (Francia)

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Sample Image Click on image to enlarge
  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 MECHANISM OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INESIGHT

4.1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: LAWS AND REGULATIONS

4.2 PRINCIPLES FOR THE DEVELOPMENT OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) GUIDELINES

4.3 HIPAA COMPLIANCE FOR PRESCRIPTION DIGITAL THERAPEUTICS (PDTX)

5 EPIDERMOLOGY

6 PIPELINE ANALYSIS

6.1 LIST OF PIPELINE PRODUCTS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 PRESENCE OF PRODUCT PIPELINE

7.1.2 INCREASING PREVALANCE OF DISEASES

7.1.3 HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS

7.1.4 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES

7.1.5 PRESENCE OF REIMBURSEMENT

7.2 RESTRAINTS

7.2.1 UNAFFORDABILITY OF DIGITAL THERAPEUTICS

7.2.2 PRIVACY ISSUES IN PRESCRIPTION DIGITAL HEALTHCARE

7.2.3 RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDERS

7.3 OPPORTUNITIES

7.3.1 INCREASING FUNDING ACTIVITIES

7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

7.3.3 EXPLORATION OF EMERGING MARKET

7.3.4 INCREASING HEALTHCARE EXPENDITURE

7.4 CHALLENGES

7.4.1 LACK OF SKILLED RESOURCES

7.4.2 EXISTENCE OF TRADITIONAL MEDICATIONS

7.4.3 LONG APPROVAL PROCEDURE

8 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

8.1 PRICE IMPACT

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC DECISIONS FOR MANUFACTURERS

8.5 CONCLUSION

9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM

9.1 OVERVIEW

9.2 INPUT MECHANISMS

9.2.1 PATIENT DATA COLLECTION

9.2.1.1 Cognition

9.2.1.2 Mood

9.2.1.3 Memory

9.2.1.4 Concentration

9.2.1.5 Familial Recognition

9.2.1.6 Others

9.2.2 DEXTERITY OR STEADINESS MEASUREMENT

9.2.2.1 Range of Motion Tests

9.2.2.2 Stretching

9.2.2.3 Others

9.2.3 AUDIO ANALYSIS

9.2.3.1 Shakiness

9.2.3.2 Voice Quality

9.2.3.3 Others

9.2.3.4 Screen

9.2.3.5 Accelerometer

9.2.3.6 Microphone

9.3 OUTPUT MECHANISMS

9.3.1 PATIENT COMMUNICATION

9.3.1.1 Professional Coaching

9.3.1.2 Peer-to-Peer Support

9.3.1.3 Others

9.3.2 ADHERENCE PROMPTS

9.3.2.1 Sleep

9.3.2.2 Diet

9.3.2.3 Inactivity

9.3.2.4 Others

9.3.3 CONTENT DELIVERY

9.3.3.1 Blogs

9.3.3.2 Tips

9.3.3.3 Videos

9.3.3.4 FAQs

9.3.3.5 Others

9.3.3.6 Chat

9.3.3.7 Notification

10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY

10.1 OVERVIEW

10.2 MEDICATION AUGMENTATION

10.3 MEDICATION REPLACEMENT

11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT

11.1 OVERVIEW

11.2 OUTPATIENT TREATMENT

11.2.1 COGNITIVE BEHAVIOR THERAPY (CBT)

11.2.2 CONTINGENCY MANAGEMENT

11.2.3 CRAVING OR TRIGGER ASSESSMENT

11.2.4 FLUENCY TRAINING

11.2.5 TRANSMUCOSAL BUPRENORPHINE

11.2.6 OTHERS

11.3 MONOTHERAPY

11.3.1 COGNITIVE RESTRUCTURING

11.3.2 INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBT)

11.3.3 OTHERS

12 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE

12.1 OVERVIEW

12.2 4.2 SOFTWARE FOR DIABETES

12.3 SOFTWARE FOR MENTAL HEALTH

12.4 SOFTWARE FOR RESPIRATORY CONDITIONS

12.5 SOFTWARE FOR OPIOID USE DISORDER

12.6 OTHERS

13 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES

13.1 OVERVIEW

13.2 BEHAVIORAL MICROSERVICES

13.2.1 PHYSICAL ACTIVITY

13.2.2 TELEMEDICINE

13.2.3 CONTROLLED BREATHING

13.2.4 MINDFULNESS TRAINING

13.2.5 RELAXATION TECHNIQUE

13.2.6 DIET OPTIMIZATION

13.2.7 OTHERS

13.3 MEDICAL MICROSERVICES

13.3.1 MEDICATION MANAGEMENT SYSTEM

13.3.2 PATIENT HEALTH QUESTIONNAIRE

13.3.3 HEALTH RECOVERED ENGINE

13.3.4 FAGERSTRÖM TEST

13.3.5 MORISKY MEDICATION ADHERENCE SCALE

13.3.6 FINANCIAL SAVING ENGINE

13.3.7 OTHERS

14 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY

14.1 OVERVIEW

14.2 ANDROID

14.2.1 SMARTPHONE

14.2.2 TABLET

14.3 OS

14.3.1 SMARTPHONE

14.3.2 TABLET

14.4 WINDOWS

14.4.1 SMARTPHONE

14.4.2 TABLET

15 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE

15.1 OVERVIEW

15.2 NATIVE APPS

15.3 WEB APPS

16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION

16.1 OVERVIEW

16.2 METABOLIC CONDITIONS

16.3 MAJOR DEPRESSIVE DIORDER (MDD)

16.4 RESPIRATORY

16.5 CARDIOVASCULAR

16.6 SUBSTANCE USE DISORDER (SUD)

16.7 OPIOID USE DISORDERS (OUD)

16.8 INSOMNIA

16.9 PAIN MANAGEMENT

16.1 ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

16.11 MOVEMENT DISORDER

16.12 INFLAMMATION

16.13 ONCOLOGY

16.14 MIGRAINE

16.15 ALZHEIMER’S DISEASE

16.16 EPILEPSY

16.17 MULTIPLE SCLEROSIS

16.18 AUSTISM SPECTRUM DISORDER

16.19 OTHERS

17 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS

17.1 OVERVIEW

17.2 ADULTS

17.3 CHILDREN

18 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY GEOGRAPHY

18.1 ASIA -PACIFIC

18.1.1 JAPAN

18.1.2 CHINA

18.1.3 AUSTRALIA

18.1.4 SOUTH KOREA

18.1.5 INDIA

18.1.6 SINGAPORE

18.1.7 THAILAND

18.1.8 MALAYSIA

18.1.9 INDONESIA

18.1.10 PHILIPPINES

18.1.11 VIETNAM

18.1.12 REST OF ASIA- PACIFIC

19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY LANDSCAPE

19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

20 SWOT ANALYSIS

21 COMPANY PROFILE

21.1 OMADA HEALTH, INC.

21.1.1 COMPANY SNAPSHOT

21.1.2 PRODUCT PORTFOLIO

21.1.3 RECENT DEVELOPMENTS

21.2 RESMED

21.2.1 COMPANY SNAPSHOT

21.2.2 REVENUE ANALYSIS

21.2.3 COMPANY SHARE ANALYSIS

21.2.4 PRODUCT PORTFOLIO

21.2.5 RECENT DEVELOPMENTS

21.3 SAMSUNG

21.3.1 COMPANY SNAPSHOT

21.3.2 REVENUE ANALYSIS

21.3.3 COMPANY SHARE ANALYSIS

21.3.4 PRODUCT PORTFOLIO

21.3.5 RECENT DEVELOPMENT

21.4 GAIA AG

21.4.1 COMPANY SNAPSHOT

21.4.2 COMPANY SHARE ANALYSIS

21.4.3 PRODUCT PORTFOLIO

21.4.4 RECENT DEVELOPMENTS

21.5 PEAR THERAPEUTICS, INC.

21.5.1 COMPANY SNAPSHOT

21.5.2 COMPANY SHARE ANALYSIS

21.5.3 PRODUCT PORTFOLIO

21.5.4 RECENT DEVELOPMENTS

21.6 WELLDOC’S BLUESTAR

21.6.1 COMPANY SNAPSHOT

21.6.2 PRODUCT PORTFOLIO

21.6.3 RECENT DEVELOPMENTS

21.7 SOLERA NETWORK

21.7.1 COMPANY SNAPSHOT

21.7.2 PRODUCT PORTFOLIO

21.7.3 RECENT DEVELOPMENTS

21.8 AKILI INTERACTIVE LABS, INC.

21.8.1 COMPANY SNAPSHOT

21.8.2 PRODUCT PORTFOLIO

21.8.3 RECENT DEVELOPMENTS

21.9 BETTER THERAPEUTICS, LLC

21.9.1 COMPANY SNAPSHOT

21.9.2 PIPELINE PRODUCT PORTFOLIO

21.9.3 RECENT DEVELOPMENTS

21.1 BIGHEALTH

21.10.1 COMPANY SNAPSHOT

21.10.2 SOLUTION PORTFOLIO

21.10.3 RECENT DEVELOPMENT

21.11 BIOFOURMIS

21.11.1 COMPANY SNAPSHOT

21.11.2 PRODUCT PORTFOLIO

21.11.3 RECENT DEVELOPMENTS

21.12 CLICK THERAPEUTICS, INC.

21.12.1 COMPANY SNAPSHOT

21.12.2 PRODUCT PORTFOLIO

21.12.3 RECENT DEVELOPMENTS

21.13 HAPPIFY, INC.

21.13.1 COMPANY SNAPSHOT

21.13.2 PRODUCT PORTFOLIO

21.13.3 RECENT DEVELOPMENTS

21.14 LIMBIX HEALTH, INC.

21.14.1 COMPANY SNAPSHOT

21.14.2 PRODUCT PORTFOLIO

21.14.3 RECENT DEVELOPMENTS

21.15 NATURALCYCLES NORDIC AB

21.15.1 COMPANY SNAPSHOT

21.15.2 PRODUCT PORTFOLIO

21.15.3 RECENT DEVELOPMENTS

21.16 NUVOAIR AB

21.16.1 COMPANY SNAPSHOT

21.16.2 PRODUCT PORTFOLIO

21.16.3 RECENT DEVELOPMENTS

21.17 SENSYNE HEALTH PLC

21.17.1 COMPANY SNAPSHOT

21.17.2 REVENUE ANALYSIS

21.17.3 PRODUCT PORTFOLIO

21.17.4 RECENT DEVELOPMENTS

21.18 VOLUNTIS

21.18.1 COMPANY SNAPSHOT

21.18.2 REVENUE ANALYSIS

21.18.3 PRODUCT PORTFOLIO

21.18.4 RECENT DEVELOPMENTS

21.19 XEALTH

21.19.1 COMPANY SNAPSHOT

21.19.2 PRODUCT PORTFOLIO

21.19.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

Lista de Tablas

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS

TABLE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)

TABLE 4 ASIA-PACIFIC INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 5 ASIA-PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 6 ASIA-PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 7 ASIA-PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 8 ASIA-PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 9 ASIA-PACIFICINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 10 ASIA-PACIFIC OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 11 ASIA-PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 13 ASIA-PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 14 ASIA-PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 15 ASIA-PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)

TABLE 17 ASIA-PACIFIC MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 18 ASIA-PACIFIC MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 22 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 23 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)

TABLE 31 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 32 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 33 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 34 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 40 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 41 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)

TABLE 43 ASIA-PACIFIC NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 44 ASIA-PACIFIC WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 47 ASIA-PACIFIC MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 48 ASIA-PACIFIC RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 49 ASIA-PACIFIC CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 50 ASIA-PACIFIC SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 51 ASIA-PACIFIC OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 52 ASIA-PACIFIC INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 53 ASIA-PACIFIC PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 54 ASIA-PACIFIC ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 55 ASIA-PACIFIC MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 56 ASIA-PACIFIC INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 57 ASIA-PACIFIC ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 58 ASIA-PACIFIC MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 59 ASIA-PACIFIC ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 60 ASIA-PACIFIC EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 61 ASIA-PACIFIC MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 62 ASIA-PACIFIC AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 63 ASIA-PACIFIC OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 64 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)

TABLE 65 ASIA-PACIFIC ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 66 ASIA-PACIFIC CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 67 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 68 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 69 ASIA- PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 70 ASIA- PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 71 ASIA- PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 72 ASIA- PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 73 ASIA- PACIFIC INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 74 ASIA- PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 75 ASIA- PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 76 ASIA- PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 77 ASIA- PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 78 ASIA- PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 79 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 80 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 81 ASIA- PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 82 ASIA- PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 83 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 84 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 85 ASIA- PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 86 ASIA- PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 87 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 88 ASIA- PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 89 ASIA- PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 90 ASIA- PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 91 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 92 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 93 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 94 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 95 JAPAN INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 96 JAPAN PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 97 JAPAN DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 98 JAPAN AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 99 JAPAN INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 100 JAPAN OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 101 JAPAN PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 102 JAPAN ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 103 JAPAN CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 104 JAPAN OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 105 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 106 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 107 JAPAN OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 108 JAPAN MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 109 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 110 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 111 JAPAN BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 112 JAPAN MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 113 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 114 JAPAN ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 115 JAPAN IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 116 JAPAN WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 117 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 118 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 119 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 120 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 121 CHINA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 122 CHINA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 123 CHINA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 124 CHINA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 125 CHINA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 126 CHINA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 127 CHINA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 128 CHINA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 129 CHINA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 130 CHINA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 131 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 132 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 133 CHINA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 134 CHINA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 135 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 136 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 137 CHINA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 138 CHINA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 139 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 140 CHINA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 141 CHINA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 142 CHINA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 143 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 144 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 145 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 146 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 147 AUSTRALIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 148 AUSTRALIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 149 AUSTRALIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 150 AUSTRALIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 151 AUSTRALIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 152 AUSTRALIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 153 AUSTRALIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 154 AUSTRALIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 155 USTRALIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 156 AUSTRALIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 157 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 158 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 159 AUSTRALIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 160 AUSTRALIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 161 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 162 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 163 AUSTRALIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 164 AUSTRALIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 165 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 166 AUSTRALIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 167 AUSTRALIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 168 AUSTRALIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 169 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 170

TABLE 171 USTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 172 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 173 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 174 SOUTH KOREA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 175 SOUTH KOREA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 176 SOUTH KOREA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 177 SOUTH KOREA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 178 SOUTH KOREA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 179 SOUTH KOREA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 180 SOUTH KOREA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 181 SOUTH KOREA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 182 SOUTH KOREA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 183 SOUTH KOREA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 184 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 185 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 186 SOUTH KOREA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 187 SOUTH KOREA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 188 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 189 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 190 SOUTH KOREA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 191 SOUTH KOREA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 192 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 193 SOUTH KOREA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 194 SOUTH KOREA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 195 SOUTH KOREA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 196 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 197 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 198 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 199 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 200 INDIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 201 INDIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 202 INDIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 203 INDIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 204 INDIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 205 INDIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 206 INDIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 207 INDIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 208 INDIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 209 INDIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 210 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 211 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 212 INDIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 213 INDIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 214 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 215 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 216 INDIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 217 INDIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 218 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 219 INDIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 220 INDIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 221 INDIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 222 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 223 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 224 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 225 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 226 SINGAPORE INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 227 SINGAPORE PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 228 SINGAPORE DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 229 SINGAPORE AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 230 SINGAPORE INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 231 INGAPORE OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 232 SINGAPORE PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 233 SINGAPORE ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 234 SINGAPORE CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 235 SINGAPORE OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 236 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 237 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 238 SINGAPORE OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 239 SINGAPORE MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 240 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 241 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 242 SINGAPORE BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 243 SINGAPORE MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 244 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 245 SINGAPORE ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 246 SINGAPORE IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 247 SINGAPORE WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 248 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 249 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 250 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 251 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 252 THAILAND INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 253 THAILAND PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 254 THAILAND DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 255 THAILAND AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 256 THAILAND INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 257 THAILAND OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 258 THAILAND PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 259 THAILAND ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 260 THAILAND CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 261 THAILAND OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 262 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 263 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 264 THAILAND OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 265 THAILAND MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 266 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 267 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 268 THAILAND BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 269 THAILAND MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 270 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 271 THAILAND ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 272 THAILAND IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 273 THAILAND WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 274 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 275 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 276 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 277 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 278 MALAYSIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 279 MALAYSIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 280 MALAYSIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 281 MALAYSIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 282 MALAYSIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 283 MALAYSIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 284 MALAYSIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 285 MALAYSIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 286 MALAYSIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 287 MALAYSIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 288 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 289 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 290 MALAYSIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 291 MALAYSIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 292 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 293 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 294 MALAYSIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 295 MALAYSIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 296 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 297 MALAYSIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 298 MALAYSIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 299 MALAYSIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 300 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 301 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 302 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 303 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 304 INDONESIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 305 INDONESIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 306 INDONESIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 307 INDONESIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 308 INDONESIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 309 INDONESIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 310 INDONESIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 311 INDONESIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 312 INDONESIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 313 INDONESIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 314 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 315 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 316 INDONESIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 317 INDONESIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 318 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 319 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 320 INDONESIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 321 INDONESIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 322 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 323 INDONESIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 324 INDONESIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 325 INDONESIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 326 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 327 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 328 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 329 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 330 PHILIPPINES INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 331 PHILIPPINES PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 332 PHILIPPINES DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 333 PHILIPPINES AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 334 PHILIPPINES INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 335 HILIPPINES OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 336 PHILIPPINES PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 337 PHILIPPINES ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 338 PHILIPPINES CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 339 PHILIPPINES OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 340 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 341 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 342 PHILIPPINES OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 343 PHILIPPINES MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 344 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 345 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 346 PHILIPPINES BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 347 PHILIPPINES MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 348 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 349 PHILIPPINES ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 350 PHILIPPINES IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 351 PHILIPPINES WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 352 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 353 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 354 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 355 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 356 VIETNAM INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 357 VIETNAM PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 358 VIETNAM DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 359 VIETNAM AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 360 VIETNAM INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 361 VIETNAM OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 362 VIETNAM PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 363 VIETNAM ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 364 VIETNAM CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 365 VIETNAM OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 366 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 367 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 368 VIETNAM OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 369 VIETNAM MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 370 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 371 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 372 VIETNAM BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 373 VIETNAM MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 374 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 375 VIETNAM ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 376 VIETNAM IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 377 VIETNAM WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 378 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 379 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 380 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 381 REST OF ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

 

Lista de figuras

 

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 12 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES AND HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS IS DRIVING THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 13 INPUT MECHANISMS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN 2020 & 2027

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

FIGURE 15 DEATH CAUSE IN EUROPEAN UNION IN 2016

FIGURE 16 OCCURRENCE OF MIGRAINE AS PER THE AUSTRALIAN AND NEW ZEALAND ASSOCIATION OF NEUROLOGISTS ANNUAL SCIENTIFIC MEETING 2017

FIGURE 17 PROJECTED NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (IN MILLIONS)

FIGURE 18 PERCENTAGE OF INTERNET USERS IN 2016 AND 2019

FIGURE 19 HEALTHCARE EXPENDITURE IN 2016 AND 2019

FIGURE 20 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019

FIGURE 21 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019-2027 (USD MILLION)

FIGURE 22 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, CAGR (2020-2027)

FIGURE 23 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019

FIGURE 25 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019-2027 (USD MILLION)

FIGURE 26 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, CAGR (2020-2027)

FIGURE 27 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019

FIGURE 29 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)

FIGURE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, CAGR (2020-2027)

FIGURE 31 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019

FIGURE 33 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019-2027 (USD MILLION)

FIGURE 34 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, CAGR (2020-2027)

FIGURE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019

FIGURE 37 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019-2027 (USD MILLION)

FIGURE 38 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, CAGR (2020-2027)

FIGURE 39 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, LIFELINE CURVE

FIGURE 40 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019

FIGURE 41 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019-2027 (USD MILLION)

FIGURE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, CAGR (2020-2027)

FIGURE 43 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, LIFELINE CURVE

FIGURE 44 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019

FIGURE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019-2027 (USD MILLION)

FIGURE 46 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, CAGR (2020-2027)

FIGURE 47 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, LIFELINE CURVE

FIGURE 48 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019

FIGURE 49 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)

FIGURE 50 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, CAGR (2020-2027)

FIGURE 51 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 52 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019

FIGURE 53 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019-2027 (USD MILLION)

FIGURE 54 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, CAGR (2020-2027)

FIGURE 55 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, LIFELINE CURVE

FIGURE 56 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SNAPSHOT (2019)

FIGURE 57 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019)

FIGURE 58 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2020 & 2027)

FIGURE 59 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019 & 2027)

FIGURE 60 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM (2020-2027)

FIGURE 61 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY SHARE 2019 (%)

 

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

The market value for Asia-Pacific Prescription Digital Therapeutics (PDTx) Market is expected USD 545.70 million by 2029.
The Prescription Digital Therapeutics (PDTx) Market is to grow at a CAGR of 24.2% during the forecast period of 2022 to 2029
On the basis of application, the Asia-Pacific Prescription Digital Therapeutics (PDTx) Marketis segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others.
The major players operating in the Asia-Pacific Prescription Digital Therapeutics (PDTx) Market are ResMed (US), SAMSUNGHEALTHCARE (South Korea), Biofourmis (US), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (US), Voluntis (France).

Explorar páginas relacionadas

Banner